Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company’s Integra Pharma Solutions subsidiary. According to the update, Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. The solution allows Trxade platform independent pharmacy members to process, consolidate and ship purchase orders placed directly with Trxade Suppliers via the Trxade Prime service. “The mission of Trxade, from its inception, has been to empower and encourage growth within the independent pharmacy community,” said Trxade Group CEO and Founder Suren Ajjarapu. “The development of Trxade Prime was the result of feedback from our significant pharmacy member base on ways to enhance purchasing efficiencies and cost savings. The overwhelming feedback Trxade received includes the difficulties pharmacies face meeting multiple supplier requirements on order minimums, individual invoicing with vastly varied payment terms and the lack of consolidated information with regard to tracking multiple orders with differing delivery dates, times and shipping costs.”
To view the full press release, visit https://ibn.fm/lvc9Y
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group is an integrated drug procurement, delivery and health care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making health care services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms: (1) the Trxade B2B trading platform with around 11,800 registered pharmacies; (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division; and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.